Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Tranexamic Acid (500mg) + Ethamsylate (250mg) Tablet
Therapeutic Category
Gynecology and Fertility
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Traxlink 500 ET Tablet containing Tranexamic Acid and Ethamsylate is used for the management of excessive bleeding associated with various medical conditions. It helps reduce blood loss and supports effective hemostasis.
Tranexamic Acid works as an antifibrinolytic agent by preventing the breakdown of blood clots, while Ethamsylate helps improve capillary stability and supports normal platelet function. Together, they help control bleeding and maintain clot integrity.
The tablet is widely prescribed in gynecology, surgery, dentistry, and general medicine practice for conditions involving abnormal or excessive bleeding, leading to consistent prescription demand.
With increasing awareness of effective bleeding management and growing demand for reliable hemostatic therapies, this product offers strong business potential for retailers and distributors. Its combination formulation, established therapeutic relevance, and steady market demand make it a reliable product for growth in the hematology segment.
Some patients may experience nausea, vomiting, abdominal discomfort, diarrhea, headache, dizziness, or fatigue. Rarely, allergic reactions, visual disturbances, or thromboembolic complications such as deep vein thrombosis may occur and require immediate medical attention.
Traxlink 500 ET Tablet is indicated for heavy menstrual bleeding (menorrhagia), dysfunctional uterine bleeding, bleeding associated with surgical and dental procedures, and other conditions involving excessive capillary bleeding or abnormal blood loss as prescribed by a healthcare professional. It helps reduce bleeding volume and improve patient comfort.
This medicine should be used strictly under medical supervision. Use cautiously in patients with a history of blood clots, thromboembolic disorders, kidney impairment, or visual disturbances. Regular medical evaluation may be required in patients receiving prolonged treatment. Follow the prescribed dosage and duration carefully.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Tranexamic Acid (500mg)
Composition : Tranexamic Acid (500mg) Injection
Composition : Tranexamic Acid (500mg) + Mefenamic Acid (250mg)
Composition : Tranexamic Acid (250mg) + Glutathione (50mg)
Composition : Tranexamic Acid (250mg) + Ethamsylate (250mg)
Composition : Ethinyl Estradiol (0.03mg) + Levonorgestrel (0.15mg)
Composition : Ethinyl Estradiol (0.03mg) + Desogestrel (0.15mg)
Composition : Ethinyl Estradiol (0.03mg) + Dienogest (2mg)
Composition : Ethinyl Estradiol (0.03mg) + Drospirenone (3mg)
Composition : Ondansetron (8 mg) MD
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Tranexamic Acid 500mg + Ethamsylate 250mg Tablet has strong demand in the gynecology, women's healthcare, and hemostatic therapy segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on gynecology and specialty care portfolios.
Medical distributors and agencies can benefit from consistent demand for bleeding management under medical supervision. Tranexamic Acid 500mg is an antifibrinolytic agent that helps reduce excessive bleeding by preventing the breakdown of blood clots Ethamsylate 250mg helps improve capillary stability and supports normal hemostasis Commonly prescribed for heavy menstrual bleeding (menorrhagia), abnormal uterine bleeding, and other conditions associated with excessive bleeding as determined by healthcare professionals The combination provides effective support for controlling and managing bleeding episodes This strengthens a comprehensive gynecology and women's healthcare portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Tranexamic Acid 500mg + Ethamsylate 250mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong prescription demand in gynecology practice, repeat therapy usage, reliable supply chain support, high market acceptance, and attractive margins in the women's healthcare segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing, secure monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.